Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today’s session.
- MillerKnoll, Inc. (NASDAQ: MLKN) surged 27% to $24.31 after the company announced better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.
- Biohaven Ltd. (NYSE: BHVN) shares jumped 24.6% to $21.99.
- Ramaco Resources, Inc. (NASDAQ: METC) climbed 15.3% to $10.77.
- SoundHound AI, Inc. (NASDAQ: SOUN) rose 15% to $1.84 after DA Davidson initiated coverage on the stock with a Buy rating and $5 price target.
- Warrior Met Coal, Inc. (NYSE: HCC) climbed 10.5% to $51.93.
- Immunovant, Inc. (NASDAQ: IMVT) gained 10.2% to $44.04 as the company reported a proposed offering of $300 million of common stock.
- PROS Holdings, Inc. (NYSE: PRO) shares jumped 9.4% to $35.00. PROS Holdings is working with Qatalyst Partners to explore a sale, Reuters reported.
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) gained 8.4% to $1.8750 after the company announced a collaboration with Pfizer focused on the discovery of RNA-based drug candidates.
- Hayward Holdings, Inc. (NYSE: HAYW) climbed 8.4% to $14.53 after it was announced the company will join the S&P SmallCap 600.
- Sea Limited (NYSE: SE) climbed 8.2% to $43.43.
- TAL Education Group (NYSE: TAL) rose 7.6% to $8.53.
- Opendoor Technologies Inc. (NASDAQ: OPEN) gained 7.6% to $2.54.
- WW International, Inc. (NASDAQ: WW) rose 7.2% to $11.03. Craig-Hallum upgraded WW International from Sell to Hold.
- IonQ, Inc. (NYSE: IONQ) surged 7.2% to $14.05.
- Stevanato Group S.p.A. (NYSE: STVN) gained 6.6% to $28.85. Stephens & Co. recently initiated coverage on Stevanato with an Overweight rating and announced a price target of $33.
- Peabody Energy Corporation (NYSE: BTU) climbed 6.3% to $24.85.
- Mattel, Inc. (NASDAQ: MAT) shares rose 4.6% to $22.19. Morgan Stanley initiated coverage on Mattel with an Overweight rating and announced a price target of $27.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.